TuHURA BIOSCIENCES, INC./NV Finance Lease, Interest Expense
TuHURA BIOSCIENCES, INC./NV (HURA) reported Finance Lease, Interest Expense of $2.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:FinanceLeaseInterestExpense · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV finance lease, interest expense for the quarter ending 2026-06-30 was $2.00K.
- TuHURA BIOSCIENCES, INC./NV finance lease, interest expense for the quarter ending 2026-03-31 was $2.00K.
- TuHURA BIOSCIENCES, INC./NV finance lease, interest expense for the quarter ending 2025-12-31 was $2.00K.
- TuHURA BIOSCIENCES, INC./NV finance lease, interest expense for the quarter ending 2025-09-30 was $3.00K.
- TuHURA BIOSCIENCES, INC./NV finance lease, interest expense for fiscal 2025 was $5.00K.
| Period end | Finance Lease, Interest Expense 3 month | Finance Lease, Interest Expense 6 month | Finance Lease, Interest Expense 9 month | Finance Lease, Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-14 | $4.00K 10-Q · filed 2026-08-14 | $6.00K derived: sum of 3 quarters · filed 2026-08-14 | $9.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-15 | $4.00K derived: sum of 2 quarters · filed 2026-05-15 | $7.00K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.00K derived: sum of 2 quarters · filed 2026-03-31 | $5.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $3.00K 10-Q · filed 2025-11-14 | $3.00K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |